Rituximab impedes natural killer cell function in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients: A pilot in vitro investigation

• Autors principals: Natalie Eaton (Autor), Hélène Cabanas (Autor), Cassandra Balinas (Autor), Anne Klein (Autor), Donald Staines (Autor), Sonya Marshall-Gradisnik (Autor)
• Format: Llibre
• Publicat: BMC, 2018-03-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

Abstract Background A recent in vitro pilot investigation reported Rituximab significantly reduced natural killer (NK) cell cytotoxicity in healthy donors. Chronic fatigue syndrome/Myalgic encephalomyelitis (CFS/ME) is a debilitating disorder of unknown etiology. A consistent finding is a significan...